World-Class Business Leaders to Hold Cannabis Conferences in Bangkok and Frankfurt

Companies in the world of medical cannabis and hemp have this year a few more meeting points to discuss knowledge, strategies, and business related to the most talked-about plant of the moment. The World Class Business Leaders conferences start next week, on March 23rd and 24th in Bangkok, Thailand, and will continue in Europe, more precisely in Frankfurt, Germany, on June 14th and 15th, 2022.

The “Cannabis Business Europe 2022” takes place on June 14 and 15 in Frankfurt, Germany. Following the success of previous editions of Cannabis Business conferences in Europe, Asia, and America, this will be the World Class Business Leaders Institute’s most comprehensive cannabis conference ever, bringing together top business leaders from around the world to discuss the latest developments in the region.

If you want to find more details about the cannabis conference, and to read the latest cannabis news in the world, download for free, the Hemp.im mobile app.

Markets focused on cannabis business

Even in 2021, at the height of pandemic restrictions, the cannabis community gathered in Frankfurt to discuss vital topics for the industry. The European cannabis market is expected to reach $37 billion by 2027, up from $3.5 billion in 2021. It is also expected to grow at a rate of 29.6% from 2022 to 2027.

The market growth in Europe is attributed to the updated regulations for medical cannabis and the growth of the cannabis and hemp industry, as changes in regulations have allowed for the cultivation, processing, and trade of cannabis products across the continent.

Cultivation, legalization, and innovation in the spotlight

The Frankfurt conference will feature several pioneering companies from countries such as Germany, the Netherlands, Denmark, Portugal, Switzerland, Poland, Italy, Spain, France, Greece, the UK, Belgium, Israel, Canada and the USA.

The Cannabis Business Europe 2022 conference will present best practices on topics related to the present and future of manufacturing, cultivation, legalization, CBD and THC innovation, business development, strategies, and marketing in Europe. Attendees will be able to interact with industry pioneers, along with the cannabis value chain, and get first-hand information on the latest trends and developments in the industry.

In addition to European representatives, international companies will also be participating in the program. Paul Steckler, international managing director of Canopy Growth Corporation, Constantin von der Groeben, co-founder and managing director of Demecan, Finn Hänsel, founder and managing director of Sanity Group, Christopher Kainz, managing director of Aurora France, Arnon Heyman, CEO of Canonic, Benedikt Sons, CEO and co-founder of Cansativa, Patrick Hoffmann, co-founder of Cantourage, Francis Scanlan, managing director and founder of Cloud 9, Lorenza Romanese, Managing Director of the European Industrial Hemp Association (EIHA), Oren Shuster, founder of IM Cannabis, Peter Homberg, partner at Dentons Europe, Hanna Hlushchenko, Business Development Director at Cannexpor Pharma, Noam Chehanovsky, CSO at RCK Medical Cannabis, Robert Noveski, founder and CEO of Sinceritas and Franziska Katterbach, president of Khiron Life Sciences Europe will be some of the guest speakers to share their success stories.

The World-Class Business Leaders Institute is a global business education platform based in Austin, Texas, USA, with offices in Grambin, Germany, and Santiago, Chile.

__

(Featured image by NickyPe via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in CANNA REPORTER, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.